Skip to main content
. 2012 Feb;165(4b):1151–1162. doi: 10.1111/j.1476-5381.2011.01585.x

Table 2.

Plasma phosphorus or iron levels on Day 0 and percentage change (%) of plasma phosphorus or iron levels compared with Day 0

Phosphorus Plasma (phosphorus) (mmol·L−1) Percentage change versus Day 0 (%) Iron Plasma (iron) (µmol·L−1) Percentage change versus Day 0 (%)
Treatment Day 0 Day 5 Day 25 Day 0 Day 5 Day 25
Saline 3.3 ± 0.8 −5 −10 43.4 ± 15.6 +12 −2
Gadoterate 3.0 ± 0.2 +6 −1 42.1 ± 7.2 +21 +18
Gadodiamide 3.1 ± 0.3 −7 −13 37.1 ± 8.3 § §
Gadobutrol 2.7 ± 0.4 −8 −15 43.8 ± 9.5 +5 +3
Gadobenate 2.8 ± 0.5 −13 −15 47.8 ± 9.8 § §
Ca-DOTA 2.8 ± 0.3 −8 −15 33.5 ± 6.0 +18 +3
Ca-DTPA 2.8 ± 0.2 −30* −13 37.8 ± 8.6 § §
*

P < 0.05 versus control (saline) group.

§

Analytical interference. Uninterpretable data.